Advanced Oncotherapy (AVO)
market vs.
industry GROWTH & VALUE
| Trailing 12m | ||||
| PE Ratio (ttm) | n/a |
|
|
|
| PEG Ratio (ttm) |
|
|
||
| EPS Growth (ttm) | % |
|
|
|
| Dividend Yield (ttm) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 11.2 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 31st Dec | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | TTM | 2012E | 2013E | CAGR / Avg | |
| Revenue | £m | ||||||||||
| Operating Profit | £m | ||||||||||
| Net Profit | £m | ||||||||||
| EPS Reported | p | ||||||||||
| EPS Normalised | p | ||||||||||
| EPS Growth | % | ||||||||||
| PE Ratio | x | ||||||||||
| PEG | x | ||||||||||
| Profitability | |||||||||||
| Operating Margin | % | ||||||||||
| ROA | % | ||||||||||
| ROCE | % | ||||||||||
| ROE | % | ||||||||||
| Cashflow | |||||||||||
| Op. Cashflow ps | p | ||||||||||
| Capex ps | p | ||||||||||
| Free Cashflow ps | p | ||||||||||
| Dividends | |||||||||||
| Dividend ps | p | ||||||||||
| Dividend Growth | % | ||||||||||
| Dividend Yield | % | ||||||||||
| Dividend Cover | x | ||||||||||
| Balance Sheet | |||||||||||
| Cash etc | £m | ||||||||||
| Working Capital | £m | ||||||||||
| Net Fixed Assets | £m | ||||||||||
| Net Debt | £m | ||||||||||
| Book Value | £m | ||||||||||
| Average Shares | m | ||||||||||
| Book Value ps | p | -48.6% | |||||||||
FINANCIAL BRIEF: For the six months ended 30 June 2012, Advanced Oncotherapy PLC revenues decreased 53% to L1.4M. Net loss increased 63% to L1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Fair value adjustment to amounts recover decrease from L291K (income) to L0K, Interest Receivable and Similar Income remaining flat at L0K. more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 30th Jun '12) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: |
Advanced Oncotherapy PLC is a United Kingdom-based healthcare real estate developer. The Company develops, finances, and manages healthcare real estate facilities and related properties. It is engaged in the development of primary care facilities, from single practice surgeries to multi-occupancy health centers, including polyclinics and medical malls. Advanced Oncotherapy PLC focuses in the development and financing of dental facilities for both national health services and private patients. Its projects include Allesley park, Bishop Stortford, Epsom, Southampton gateway, West Wirral and the Folkestone health center. The Firm also provides services in the areas of briefing and business planning, site finding, programming, cost control, designing, construction, commissioning, and financing, as well as advice service on maintenance and repair issues to tenants and building occupiers, and facilities management services. In January 2013, it sold The Healthcare Property Company Limited.
Directors: David Evans (CEO) , Michael Sinclair (Fin. Dir.) 39, Donald Baladasan (COO) 37, Sneh Khemka (Secy.) ,
No. of Employees: 9 No. of Shareholders: n/a
| Last Annual | December 31st, 2011 |
| Last Interim | June 30th, 2012 |
| Shares in Issue | 359,410,368 |
| Free Float | 111.5m (31.0%) |
| Sector | Financials |
| Industry | Real Estate Operations |
| Index | FTSE Aim All Share, |
| Exchange |
London Stock Exchange (AIM) |
| Eligible for | an ISA? a SIPP? |
| Address | , MALDON, CM9 6PP, United Kingdom |
| Web | http://www.carecapital.co.uk |
| Phone | +44 20 36178730 |
| Contact | Lindsay Mair (Corporate Finance) |
| Registrar | Capita Registrars (Kent) |
| Auditors | Royce Peeling Green Ltd |
| 4th Jun | Result of Meeting |
| 3rd Jun | Collaboration with BMI Healthcare |
| 16th May | Posting of Circular |
| 3rd May | Director Appointment |
| 30th Apr | Holding(s) in Company |
| 26th Apr | Director Dealing |
Recent ↓
